Valproic acid promotes radiosensitization in meningioma stem-like cells

Hsin-Ying Clair Chiou; Wen-Kuo Lai; Li-Chun Huang; Shih-Ming Huang; Sheau-Huei Chueh; Hsin-I Ma; Dueng-Yuan Hueng

doi:10.18632/oncotarget.3692

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Valproic acid promotes radiosensitization in meningioma stem-like cells

Hsin-Ying Clair Chiou, Wen-Kuo Lai, Li-Chun Huang, Shih-Ming Huang, Sheau-Huei Chueh, Hsin-I Ma and Dueng-Yuan Hueng _

PDF | HTML | How to cite

Oncotarget. 2015; 6:9959-9969. https://doi.org/10.18632/oncotarget.3692

Metrics: PDF 1716 views | HTML 2388 views | ?

Abstract

Hsin-Ying Clair Chiou1, Wen-Kuo Lai2, Li-Chun Huang2, Shih-Ming Huang2, Sheau-Huei Chueh2, Hsin-I Ma1 and Dueng-Yuan Hueng1,2

1 Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.

2 Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, R.O.C.

Correspondence to:

Dueng-Yuan Hueng, email:

Keywords: meningioma, tumor stem-like cells, radiosensitization, valproic acid, Oct4

Received: January 05, 2015 Accepted: March 05, 2015 Published: March 29, 2015

Abstract

Although meningioma stem-like cells have been isolated and characterized, their therapeutic targeting remains a challenge. Meningioma sphere cells (MgSCs) with cancer stem cells properties show chemo- and radioresistance in comparison with meningioma adherent cells (MgACs). We tested the effect of valproic acid (VPA), a commonly used anti-epileptic drug, which passes the blood brain barrier, on cultured MgSCs. VPA reduced the viability of MgSCs and MgACs. In MgSCs, treatment with VPA increased radio-sensitivity, expression of p-cdc2, p-H2AX and cleaved caspase-3 and PARP. Anchorage-independent growth (AIG) was reduced by VPA. AIG was further reduced by combined treatment with irradiation. Expression of a stem cell marker, Oct4, was reduced by VPA. Oct4 was further decreased by combined treatment with irradiation. These results suggest that VPA may be a potential treatment for meningioma through targeting meningioma stem-like cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3692

Publication Alerts

Research Papers:

Valproic acid promotes radiosensitization in meningioma stem-like cells

Abstract